Xconomy -- Neuroptix, an Acton, MA-based developer of a diagnostic test for Alzheimer’s disease, has raised $4.6 million of a mixed offering of equity and rights that could total $9.1 million, according to an SEC filing. The company brought in $18.5 million in a Series B round of funding in 2008, led by Inventages.
